Insulin and the constituent branches of the hepatic vagus interact to modulate hypothalamic and limbic neuropeptide mRNA expression differentially

Journal of Neuroendocrinology

Volumn 20, Issue 9, 2008, Pages 1067-1077

  Warne, James P ^a   Horneman, H F ^a   Akana, S F ^a   Foster, M T ^a   Dallman, M F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Corticotrophin releasing factor; Glucocorticoids; Insulin; Neuropeptide Y; Pro opiomelanocortin; Vagus nerve

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; INSULIN; MESSENGER RNA; NEUROPEPTIDE; NEUROPEPTIDE Y; PROOPIOMELANOCORTIN; SODIUM CHLORIDE; STREPTOZOCIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; ENERGY BALANCE; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; IN SITU HYBRIDIZATION; LIMBIC CORTEX; MALE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; SELECTIVE VAGOTOMY; STREPTOZOCIN DIABETES; STRIA TERMINALIS; VAGOTOMY; VAGUS NERVE;

ANIMALS; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION; HYPOTHALAMUS; INSULIN; LIMBIC SYSTEM; LIVER; MALE; MODELS, BIOLOGICAL; NEUROPEPTIDE Y; NEUROPEPTIDES; PRO-OPIOMELANOCORTIN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STREPTOZOCIN; VAGUS NERVE;

EID: 49449115890     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2008.01766.x     Document Type: Article

References (51)

1. Benoit SC, Clegg DJ, Seeley RJ, Woods SC. Insulin and leptin as adiposity signals. Recent Prog Horm Res 2004; 59: 267-285.
2. Pocai A, Obici S, Schwartz GJ, Rossetti L. A brain-liver circuit regulates glucose homeostasis. Cell Metab 2005; 1: 53-61.
3. Obici S, Zhang BB, Karkanias G, Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 2002; 8: 1376-1382.
4. la Fleur SE, Akana SF, Manalo S, Dallman MF. Interaction between corticosterone and insulin in obesity: Regulation of lard intake and fat stores. Endocrinology 2004; 145: 2174-2185.
5. Warne JP, Horneman HF, Wick EC, Bhargava A, Pecoraro NC, Ginsberg AB, Akana SF, Dallman MF. Comparison of superior mesenteric versus jugular venous infusions of insulin in streptozotocin-diabetic rats on the choice of caloric intake, body weight, and fat stores. Endocrinology 2006; 147: 5443-5451.
6. White JD, Olchovsky D, Kershaw M, Berelowitz M. Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats. Endocrinology 1990; 126: 765-772.
7. Sahu A, Sninsky CA, Phelps CB, Dube MG, Kalra PS, Kalra SP. Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats. Endocrinology 1992; 131: 2979-2985.
8. Kim E-M, Grace MK, Welch C, Billington CJ, Levine AJ. Stz-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats. Am J Physiol 1999; 276: R1320-R1326.
9. Havel PJ, Hahn TM, Sindelar DK, G BD, Dallman MF, Weigle DS, Schwartz MW. Effects of streptozotocin diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats. Diabetes 2000; 49: 244-252.
10. Scribner KA, Walker C-D, Cascio CS, Dallman MF. Chronic streptozotocin diabetes in rats facilitates the acute stress response without altering pituitary or adrenal responsiveness to secretagogues. Endocrinology 1991; 129: 9-108.
11. Chan O, Inouye K, Akirav E, Park E, Riddell MC, Vranic M, Matthews SG. Insulin alone increases hypothalamo-pituitary-adrenal activity, and diabetes lowers peak stress responses. Endocrinology 2005; 146: 1382-1390.
12. Chavez M, Seeley RJ, Havel PJ, Friedman MI, Matson CA, Woods SC, Schwartz MW. Effect of a high fat diet on food intake and hypothalamic neuropeptide gene expression in streptozotocin diabetes. J Clin Invest 1998; 102: 340-346.
13. la Fleur SE, Ji H, Manalo S, Friedman MI, Dallman MF. The hepatic vagus mediates fat-induced inhibition of diabetic hyperphagia. Diabetes 2003; 52: 2321-2330.
14. Schwartz MW, Strack AM, Dallman MF. Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotropin releasing hormone gene expression in diabetes. Regul Pept 1997; 72: 105-112.
15. Heinrichs SC, Menzaghi F, Pich EM, Hauger RL, Koob GF. Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Res 1993; 611: 18-24.
16. Heinrichs SC, Cole BJ, Pich EM, Menzaghi F, Koob GF, Hauger RL. Endogenous corticotropin-releasing factor modulates feeding induced by neuropeptide Y or a tail-pinch stressor. Peptides 1992; 13: 879-884.
17. Lu X-Y, Barsh GS, Akil H, Watson SJ Jr. Interaction between α-melanocyte-stimulating hormone and corticotropin-releasing hormone in the regulation of feeding and hypothalamo-pituitary-adrenal responses. J Neurosci 2003; 23: 7863-7872.
18. King BM, Rossiter KN, Stines SG, Zaharan GM, Cook JT, Humprhies MD, York DA. Amygdaloid-lesion hyperphagia: Impaired response to caloric challenges and altered macronutrient selection. Am J Physiol 1998; 275: R485-R493.
19. Ciccocioppo R, Fedeli A, Economidou D, Policani F, Weiss F, Massi M. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ. J Neurosci 2003; 23: 9445-9551.
20. la Fleur SE, Manalo S, Roy M, Houshyar H, Dallman MF. Hepatic vagotomy alters limbic and hypothalamic neuropeptide responses to streptozotocin-diabetes and voluntary lard ingestion. Eur J Neurosci 2005; 21: 2733-2742.
21. Berthoud H-R, Neuhuber WL. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci 2000; 85: 1-17.
22. Warne JP, Foster MT, Horneman HF, Pecoraro NC, Ginsberg AB, Akana SF, Dallman MF. Hepatic branch vagotomy, like insulin replacement, promotes voluntary lard intake in streptozotocin-diabetic rats. Endocrinology 2007; 148: 3288-3298.
23. Warne JP, Foster MT, Horneman HF, Pecoraro NC, Ginsberg AB, Akana SF, Dallman MF. Afferent signalling through the common hepatic branch of the vagus inhibits voluntary lard intake and modifies plasma metabolite levels in rats. J Physiol 2007; 583: 455-467.
24. Warne JP, Foster MT, Horneman HF, Pecoraro NC, de Jong HK, Ginsberg AB, Akana SF, Dallman MF. The gastroduodenal branch of the common hepatic vagus regulates voluntary lard intake, fat deposition, and plasma metabolites in streptozotocin-diabetic rats. Am J Physiol Endocrinol Metab 2008; 294: E190-E200.
25. Warne JP, Horneman HF, Ginsberg AB, Pecoraro NC, Foster MT, Akana SF, Dallman MF. Mapping brain c-fos immunoreactivity after insulin-induced voluntary lard intake: Insulin- and lard-associated patterns. J Neuroendocrinol 2007; 19: 794-808.
26. Akana SF, Cascio CS, Shinsako J, Dallman MF. Corticosterone: Narrow range required for normal body and thymus weight and ACTH. Am J Physiol 1985; 249: R527-R532.
27. Ginsberg AB, Campeau S, Day HE, Spencer RL. Acute glucocorticoid pretreatment suppresses stress-induced hypothalamic-pituitary-adrenal axis hormone secretion and expression of corticotropin-releasing hormone hnRNA but does not affect c-fos mRNA or fos protein expression in the paraventricular nucleus of the hypothalamus. J Neuroendocrinol 2003; 15: 1075-1083.
28. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press, 1998.
29. Corp ES, Woods SC, Porte D Jr, Dorsa DM, Figlewicz DP, Baskin DG. Localization of 125 I-insulin binding sites in the rat hypothalamus by quantitative autoradiography. Neurosci Lett 1986; 70: 17-22.
30. Baskin DG, Sipols AJ, Schwartz MW, White MF. Immunocytochemical detection of insulin receptor substrate-1 (IRS-1) in rat brain: colocalization with phosphotyrosine. Regul Pept 1993; 48: 257-266.
31. Sipols AJ, Baskin DG, Schwartz MW. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes 1995; 44: 147-151.
32. Watts AG, Sanchez-Watts G. Region-specific regulation of neuropeptide mrnas in rat limbic forebrain neurones by aldosterone and corticosterone. J Physiol 1995; 484: 721-736.
33. Huang Q, Timofeeva E, Richard D. Corticotropin-releasing factor and its receptors in the brain of rats with insulin and corticosterone deficits. J Mol Endocrinol 2006; 37: 213-226.
34. Chan O, Chan S, Inouye K, Vranic M, Matthews SG. Molecular reguation of the hypothalamo-pituitary-adrenal axis in streptozotocin-induced diabetes: Effects of insulin treatment. Endocrinology 2001; 142: 4872-4879.
35. Pecoraro N, Reyes F, Gomez F, Bhargava A, Dallman MF. Chronic stress promotes palatable feeding, which reduces signs of stress: Feedforward and feedback effects of chronic stress. Endocrinology 2004; 145: 3754-3762.
36. Laugero KD, Bell ME, Bhatnagar S, Soriano L, Dallman MF. Sucrose ingestion normalizes central expression of corticotropin-releasing-factor messenger ribonucleic acid and energy balance in adrenalectomized rats: A glucocorticoid-metabolic-brain axis? Endocrinology 2001; 142: 2796-2804.
37. Laugero KD, Gomez F, Manalo S, Dallman MF. Corticosterone infused intracerebroventricularly inhibits energy storage and stimulates the hypothalamo-pituitary axis in adrenalectomized rats drinking sucrose. Endocrinology 2002; 143: 4552-4562.
38. Dong HW, Petrovich GD, Swanson LW. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res Brain Res Rev 2001; 38: 192-246.
39. Unger J, McNeill TH, Moxley RTI, White M, Moss A, Livingston JN. Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 1989; 31: 143-147.
40. Havrankova J, Brownstein M, Roth J. Insulin and insulin receptors in rodent brain. Diabetologia 1981; 20 (Suppl.): 268-273.
41. Fry M, Ferguson AV. The sensory circumventricular organs: Brain targets for circulating signals controlling ingestive behavior. Physiol Behav 2007; 91: 413-423.
42. Pecoraro N, Dallman MF, Warne JP, Ginsberg AB, Laugero KD, la Fleur SE, Houshyar H, Gomez F, Bhargava A, Akana SF. From malthus to motive: How the HPA axis engineers the phenotype, yoking needs to wants. Prog Neurobiol 2006; 79: 247-340.
43. Bernal-Mizrachi C, Xiaozhong L, Yin L, Knutsen RH, Howard MJ, Arends JJ, Desantis P, Coleman T, Semenkovich CF. An afferent vagal nerve pathway links hepatic PPARalpha activation to glucocorticoid-induced insulin resistance and hypertension. Cell Metab 2007; 5: 91-102.
44. Sindelar DK, Mystkowski P, Marsh DJ, Palmiter RD, Schwartz MW. Attenuation of diabetic hyperphagia in neuropeptide Y-deficient mice. Diabetes 2002; 51: 778-783.
45. Fioramonti X, Contie S, Song Z, Routh VH, Lorsignol A, Penicaud L. Characterization of glucosensing neuron subpopulations in the arcuate nucleus: Integration in neuropeptide Y and pro-opiomelanocortin networks? Diabetes 2007; 56: 1219-1227.
46. Muroya S, Yada T, Shioda S, Takigawa M. Glucose-sensitive neurons in the rat arcuate nucleus contain neuropeptide Y. Neurosci Lett 1999; 264: 113-116.
47. Mei N. Vagal glucoreceptors in the small intestine of the cat. J Physiol 1978; 282: 485-506.
48. Randich A, Spraggins DS, Cox JE, Meller ST, Kelm GR. Jejunal or portal vein infusions of lipids increase hepatic vagal afferent activity. Neuroreport 2001; 12: 3101-3105.
49. Torii K, Niijima A. Effect of lysine on afferent activity of the hepatic branch of the vagus nerve in normal and L-lysine-deficient rats. Physiol Behav 2001; 72: 685-690.
50. Savontaus E, Conwell IM, Wardlaw SL. Effects of adrenalectomy on AgRP, POMC, NPY and CART gene expression in the basal hypothalamus of fed and fasted rats. Brain Res 2002; 958: 130-138.
51. Shafique S, Dalsing MC. Vagus nerve stimulation therapy for treatment of drug-resistant epilepsy and depression. Perspect Vasc Surg Endovasc Ther 2006; 18: 323-327.